Jul 13, 2026 | Legal Compliance
If you follow wellness, anti-aging, or fitness trends, you’ve probably heard of peptides like BPC-157 or TB-500. Often marketed online as “miracle molecules” for healing injuries and turning back the clock, these compounds are currently at the center of a massive...
Feb 8, 2026 | Legal Compliance
You may have seen recent headlines that Hims & Hers pulled a planned launch of a compounded “Wegovy-like” product after pressure from the U.S. Food and Drug Administration. That alone should get the attention of any practice offering GLP-1s. But there’s a second,...
Feb 6, 2026 | Legal Compliance
Peptides have become a hot topic in medical spas, IV clinics, and wellness practices, particularly in connection with weight management, longevity, and anti-aging treatments. At the same time, peptides occupy a complex regulatory space that blends federal and state...
Jan 12, 2026 | Legal Compliance, State-Specific Regulations
What Business Owners Need to Know The medical spa industry continues to grow rapidly across New York. Regulatory scrutiny is growing even faster. In 2026, New York regulators have made one thing unmistakably clear: New York medical spas are now a priority enforcement...
Jan 5, 2026 | Legal Compliance, News
In response to the COVID-19 public health emergency, on January 31, 2020, the Drug Enforcement Administration (“DEA”) issued temporary exceptions to the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Ryan Haight Act”) and the DEA’s implementing...
Dec 18, 2025 | Legal Compliance, News
For months, we’ve been advising New York medical spa owners that enforcement risk is no longer theoretical. Now, it’s official. In December 2025, the New York City Council released a comprehensive Office of Inspector General (OIG) report on medical spas, outlining...
